The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10A | Insulins and analogues | |
| 4 | A10AE | Insulins and analogues for injection, long-acting | |
| 5 | A10AE54 | Insulin glargine and lixisenatide |
| Active Ingredient | Description | |
|---|---|---|
| Insulin glargine and Lixisenatide |
Combination of two active substances with complementary mechanisms of action to improve glycaemic control: insulin glargine, a basal insulin analogue (mainly targeting fasting plasma glucose), and lixisenatide, a GLP-1 receptor agonist (mainly targeting postprandial glucose). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| SOLIQUA Solution for injection in pre-filled pen (SoloStar) | European Medicines Agency (EU) | MPI, EU: SmPC | |
| SULIQUA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
